Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

FRA/88Q stock hub

FRA/88Q has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

FRA/88Qis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

81.5M

Frankfurt Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

FRA/88Q

In the news

Latest news · FRA/88Q

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.3P50 15.7P75 20.2

Trailing P/En/a

P25 16.4P50 20.9P75 30.4

ROE-209.3

P25 -6.7P50 8.5P75 17.2

ROIC-42.9

P25 -1.7P50 8.5P75 17.4

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All FRA/88Q market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

165

Groups with data

Currency

GBP

Showing 165 of 165 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United Kingdom
Country code	DE
Employees	110
Employees Change	26%
Employees Change Percent	30.95
Enterprise value	EUR 69.2M
Exchange	Frankfurt Stock Exchange
Financial currency	GBP
First seen	2026-05-10
Industry	Biotechnology
Isin	GB00BMCLYF79
Last refreshed	2026-05-10
Market cap	EUR 81.5M
Price	EUR 5.15
Price currency	EUR
Rev Per Employee	18,867.07x
Sector	Healthcare
Sic	2836
Symbol	fra/88Q
Website	https://www.4basebio.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-20.62%
EV Earnings	-4.11x
EV/FCF	-4.06x
EV/Sales	33.58x
FCF yield	-20.89%
P/B ratio	3.68x
P/S ratio	39.28x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross margin	61.55%
Gross Profit	EUR 1.3M
Gross Profit Growth	73.81%
Gross Profit Growth Q	197.03%
Gross Profit Growth3 Y	47.68%
Gross Profit Growth5 Y	35.58%
Net Income	EUR -16.8M
Net Income Growth Years	0%
Pretax Margin	-828.22%
Profit Per Employee	EUR -152,814
ROA	-39.27
Roa5y	-23.19
ROCE	-44.64
ROE	-209.3
Roe5y	-83.15
ROIC	-42.88

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-60.71%
Cagr3y	-9.51%
Cagr5y	5.83%
EPS Growth Years	0
Revenue Growth	198.49x
Revenue Growth Q	257.93x
Revenue Growth Years	2x
Revenue Growth3 Y	52.06x
Revenue Growth5 Y	46.02x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	EUR 0.07
Assets	EUR 43M
Cash	EUR 30.5M
Current Assets	EUR 33.2M
Current Liabilities	EUR 2.9M
Debt	EUR 18M
Debt Equity	EUR 0.81
Debt FCF	EUR -1.06
Equity	EUR 22.1M
Interest Coverage	-18.58
Liabilities	EUR 20.9M
Long Term Assets	EUR 9.8M
Long Term Liabilities	EUR 17.9M
Net Cash	EUR 12.5M
Net Cash By Market Cap	EUR 15.28
Net Debt Equity	EUR -0.56
Tangible Book Value	EUR 20.6M
Tangible Book Value Per Share	EUR 1.33

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	11.36
Inventory Turnover	1.54
Net Working Capital	EUR 223,987
Quick ratio	10.38
Working Capital	EUR 30.5M
Working Capital Turnover	EUR 0.14

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-15.92%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-60.69%
200-day SMA	7.9
3Y total return	-25.9%
50-day SMA	5.77
50-day SMA vs 200-day SMA	50under200
5Y total return	32.73%
All Time High	20.6
All Time High Change	-75%
All Time High Date	2024-06-14
All Time Low	3.55
All Time Low Change	45.07%
All Time Low Date	2021-04-20
ATR	0.2
Ch YTD	-18.9
High	5.15
High52	13.1
High52 Date	2025-06-09
High52ch	-60.69%
Low	5.15
Low52	5
Low52 Date	2026-05-07
Low52ch	3%
Ma50ch	-10.79%
Price vs 200-day SMA	-34.83%
RSI	36.73
RSI Monthly	29.59
RSI Weekly	24.61
Sharpe ratio	-1.52x
Sortino ratio	-1.9
Total Return	-15.92%
Tr YTD	-18.9
Tr1m	-6.36%
Tr1w	-1.9%
Tr3m	-18.25%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR -17.9M
Operating margin	-861.8

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	5,679,888%
Net Borrowing	-457,786.7
Shares Insiders	11.78%
Shares Institutions	40.84%
Shares Qo Q	14.52%
Shares Yo Y	15.92%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	EUR -17M
Average Volume	113.9x
Bv Per Share	1.43
CAPEX	EUR -969,443
Ch1m	-6.36
Ch1w	-1.9
Ch1y	-60.69
Ch3m	-18.25
Ch3y	-25.9
Ch5y	32.73
Ch6m	-38.69
Change	-1.9%
Change From Open	0
Close	5.25
Days Gap	-1.9
Depreciation Amortization	729,453
Earnings Date	2026-05-22
EBIT	EUR -17.9M
EBITDA	EUR -17.2M
EPS	EUR -1.16
F Score	3
FCF	EUR -17M
FCF EV Yield	-24.62x
Financing CF	45,056,354
Fiscal Year End	December
Founded	2,008
Income Tax	EUR -379,144
Investing CF	-1,770,896
Is Primary Listing	0
Last Earnings Date	2026-01-02
Last Report Date	2025-06-30
Ma150	6.97
Ma150ch	-26.12%
Ma20	5.54
Ma20ch	-7.01%
Net CF	27,293,731
Next Earnings Date	2026-05-22
Open	5.15
Ppne	5,032,185.6
Price Date	2026-05-08
Ptbv Ratio	3.95
Relative Volume	0.07x
Revenue	2,075,378x
Tax By Revenue	-18.27x
Tr6m	-38.69%
Z Score	3.22

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does FRA/88Q pay a dividend?

Capital-return profile for this ticker.

Performance

FRA/88Q stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns FRA/88Q?

Insider, institutional, and short-interest positioning.

Institutional ownership

+40.8%

Share of float held by funds and institutions

Insider ownership

+11.8%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+15.9%

Negative means the company is buying back shares.

Technical

FRA/88Q momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

36.7

Neutral momentum band

Price vs 200-day MA

-34.8%

50/200-day relationship not available

Beta (5Y)

n/a

Sensitivity to the broader market

Sharpe ratio

-1.52

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About FRA/88Q

Hub-level FAQ points readers to the deeper analysis pages.

What is the current fra/88Q stock rating?

fra/88Q is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full fra/88Q analysis?

The full report lives at /stocks/fra/88Q/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for fra/88Q?

The latest report frames fra/88Q around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the fra/88Q page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.